Elisigen

Seoul, South Korea · Founded 2018 · Privately Held (backing)

Developer of an adeno-associated virus (AAV) gene therapy designed to improve the quality of life of patients. Elisigen is based in Seoul, South Korea and was founded in 2018. Its last reported valuation was $74.5 million in Jul 2021. It has raised $83.7 million.

Last reported valuation

$74.5M

Oct 2026

Priced at

—

Total raised

$83.7M

Last round

—

How much has Elisigen raised?

$83.7Macross 0 recorded rounds

Free account

More of Elisigen with a free account

·The complete investor list: 24 names
·Watch Elisigen: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Elisigen investors

24 investors are on record for Elisigen, including KB Investment, Korea Investment Partners, Korea Development Bank and Partners Investment. By type, the record holds 6 venture capital firms and 1 private equity firm.

For fundraisers

Raising for a company like Elisigen?

24 investors have backed Elisigen.

See all 24 investors →

Frequently asked about Elisigen

How much has Elisigen raised?: Elisigen has raised $83.7M in total across 0 recorded funding rounds.